ILD Seen in Some Taking ADC for Brain Cancer Metastases



A systematic review and meta-analysis evaluate treatment-emergent adverse events associated with trastuzumab deruxtecan in patients with breast cancer brain metastases.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/ild-seen-some-taking-adc-brain-cancer-metastases-2026a10003pg?src=rss

Author :

Publish date : 2026-02-05 13:48:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version